Titre : Vaccins atténués

Vaccins atténués : Questions médicales fréquentes

Termes MeSH sélectionnés :

Patch Tests

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment savoir si un vaccin est atténué ?

Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents.
Vaccins atténués Agents pathogènes Immunisation
#2

Quels tests pour vérifier l'efficacité d'un vaccin atténué ?

Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination.
Tests sérologiques Efficacité des vaccins Immunité

Symptômes 2

#1

Quels symptômes peuvent apparaître après un vaccin atténué ?

Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir.
Réactions aux vaccins Effets secondaires Fièvre
#2

Les vaccins atténués causent-ils des maladies ?

Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée.
Maladies infectieuses Réactions indésirables Vaccins

Prévention 2

#1

Comment se préparer avant de recevoir un vaccin atténué ?

Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination.
Préparation à la vaccination Antécédents médicaux Vaccins
#2

Les vaccins atténués sont-ils sûrs pour tous ?

Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées.
Immunodépression Sécurité des vaccins Vaccins atténués

Traitements 2

#1

Que faire en cas de réaction sévère à un vaccin atténué ?

Consulter immédiatement un professionnel de santé pour évaluer la situation.
Réactions allergiques Traitement médical Vaccins
#2

Les vaccins atténués nécessitent-ils un traitement préventif ?

Non, mais des antécédents médicaux doivent être évalués avant la vaccination.
Antécédents médicaux Prévention Vaccins

Complications 2

#1

Quelles complications peuvent survenir avec un vaccin atténué ?

Des complications rares incluent des infections chez les personnes immunodéprimées.
Complications Infections Vaccins atténués
#2

Les complications des vaccins atténués sont-elles fréquentes ?

Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance.
Surveillance médicale Effets indésirables Vaccins

Facteurs de risque 2

#1

Qui devrait éviter les vaccins atténués ?

Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins.
Immunodépression Grossesse Vaccins atténués
#2

Les antécédents d'allergies influencent-ils la vaccination ?

Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable.
Allergies Évaluation médicale Vaccins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins atténués : Questions médicales les plus fréquentes", "headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-19", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins atténués" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "about": { "@type": "MedicalCondition", "name": "Vaccins atténués", "alternateName": "Vaccines, Attenuated", "code": { "@type": "MedicalCode", "code": "D014613", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Aitor Nogales", "url": "https://questionsmedicales.fr/author/Aitor%20Nogales", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com." } }, { "@type": "Person", "name": "Charles Grose", "url": "https://questionsmedicales.fr/author/Charles%20Grose", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA." } }, { "@type": "Person", "name": "Manish Patel", "url": "https://questionsmedicales.fr/author/Manish%20Patel", "affiliation": { "@type": "Organization", "name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov." } }, { "@type": "Person", "name": "Jessie R Chung", "url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung", "affiliation": { "@type": "Organization", "name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The use of carvone in consecutive patch testing.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36399045", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cod.14249" } }, { "@type": "ScholarlyArticle", "name": "Use of sorbitan sesquioleate in patch test preparations and patch testing with the substance-What do our results mean?", "datePublished": "2022-11-01", "url": "https://questionsmedicales.fr/article/36305668", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cod.14239" } }, { "@type": "ScholarlyArticle", "name": "The prevalence and relevance of patch testing with textile dyes.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36461774", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cod.14260" } }, { "@type": "ScholarlyArticle", "name": "Patch test results in dental staff with dermatitis.", "datePublished": "2023-06-23", "url": "https://questionsmedicales.fr/article/37353940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ajd.14112" } }, { "@type": "ScholarlyArticle", "name": "Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery.", "datePublished": "2024-05-01", "url": "https://questionsmedicales.fr/article/38721959", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.15586/aei.v52i3.1024" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins atténués", "item": "https://questionsmedicales.fr/mesh/D014613" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins atténués - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins atténués", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins atténués", "description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins atténués", "description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins atténués", "description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins atténués", "description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins atténués", "description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins atténués", "description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Patch+Tests#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si un vaccin est atténué ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents." } }, { "@type": "Question", "name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination." } }, { "@type": "Question", "name": "Quels symptômes peuvent apparaître après un vaccin atténué ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Les vaccins atténués causent-ils des maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée." } }, { "@type": "Question", "name": "Comment se préparer avant de recevoir un vaccin atténué ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination." } }, { "@type": "Question", "name": "Les vaccins atténués sont-ils sûrs pour tous ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées." } }, { "@type": "Question", "name": "Que faire en cas de réaction sévère à un vaccin atténué ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Consulter immédiatement un professionnel de santé pour évaluer la situation." } }, { "@type": "Question", "name": "Les vaccins atténués nécessitent-ils un traitement préventif ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un vaccin atténué ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des infections chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Les complications des vaccins atténués sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance." } }, { "@type": "Question", "name": "Qui devrait éviter les vaccins atténués ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins." } }, { "@type": "Question", "name": "Les antécédents d'allergies influencent-ils la vaccination ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 13/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

None None

3 publications dans cette catégorie

Publications dans "Vaccins atténués" :

Aitor Nogales

3 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.

Charles Grose

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.

Manish Patel

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.

Jessie R Chung

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.

Brendan Flannery

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.

Ashley L Fowlkes

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

Alicia M Fry

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

James Weger-Lucarelli

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
  • Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.

Anne A Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Michael D Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Pilar Blanco-Lobo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.

Luis Martínez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.

Stephen Higgs

2 publications dans cette catégorie

Affiliations :
  • Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.

Laura Rodriguez

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
  • Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.

Michael E Smith

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Kayan Dunnigan

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Manjusha Gaglani

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.

Mark G Thompson

2 publications dans cette catégorie

Affiliations :
  • U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.

Luis Martinez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.

Sources (10000 au total)

The use of carvone in consecutive patch testing.

Carvone (l-carvone) is a mint-tasting flavour additive that most of us is exposed to and can cause allergic contact reactions.... To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population.... A retrospective analysis of dermatitis patients consecutively tested with carvone from 2017 to 2021. Data were retrieved from the department's patch-test database.... Of 3554 patients tested with carvone, 28 (0.79%) had a positive reaction. Carvone-positive patients had higher mean age, were significantly more likely female (p < 0.001) and had often an intraoral/li... The study suggests that a significant fraction of relevant carvone contact allergies may be overlooked if the allergen is not tested. Furthermore, as the exposure is widespread, inclusion of carvone i...

Use of sorbitan sesquioleate in patch test preparations and patch testing with the substance-What do our results mean?

Sorbitan sesquioleate (SSO) is a sorbitan fatty acid ester, an emulsifier used in topical products and certain patch test preparations. SSO may affect the patch test results. It has been debated wheth... To report the prevalence and simultaneous reactions of SSO with other patch test preparations containing SSO as an emulsifier.... A retrospective analysis of 3539 dermatitis patients who underwent patch testing from 2016 to 2020 was performed.... The 5-year SSO contact allergy prevalence was 0.48%, and 1.3% had a doubtful reaction. Patients with a stronger positive reaction (2+, 3+) were more likely to react simultaneously to other allergen pr... Patch testing with allergen preparations containing SSO affected the patch test interpretation. Fragrance contact allergy could not be ruled out when a patient simultaneously reacted to SSO and FM I. ...

The prevalence and relevance of patch testing with textile dyes.

Textile dye mix (TDM) is included in the European baseline series (EBS), but it is unknown if TDM identifies all patients with a textile dye allergy.... To assess the added value of performing patch testing with individual textile dyes in addition to TDM.... Two hundred and nine patients suspected to have a contact allergy to textile dyes were patch tested between January 2015 and December 2021 with the EBS, as well as an individual textile dye test serie... Fifty-four patients (25.8%) tested positive for TDM or an individual textile dye. Disperse Orange 3 (9.6%) followed by Disperse Blue 106 (4.8%) were the most common individual textile dyes causing a p... It is beneficial to test individual textile dyes in addition to TDM in patients suspected of having a textile dye allergy. Otherwise, 46.3% of the dye positive patients and 35.7% of the patients with ...

Patch test results in dental staff with dermatitis.

Dental workers are exposed to allergenic materials in the workplace.... To summarize patch test results in dental staff with work-related dermatitis.... Cross-sectional study of dental staff with dermatitis was conducted. Symptoms, clinical findings and results from patch tests with 40 dental allergens were summarized.... Of 329 participants, 155 (47.1%) had at least one positive patch reaction. The highest frequency of positive reactions was observed for metals (38.6%), acrylics (7.3%) and additives in acrylic resins ... Almost half of the dental staff with dermatitis had at least one positive patch test and approximately 12% had current occupational relevance of the allergens. Our results underscore the importance of...

Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery.

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease mainly affecting children. Similarly, Allergic contact dermatitis (ACD) is an inflammatory skin disease, but unlike AD it re... In this cross-sectional transversal study, we performed a PT with 30 sensitizers in 26 children with AD, selected according to established criteria for suspected ACD, and treated at an AD center of a ... In all, 23 (88.5%) patients reacted to at least one allergen, 21 (80.7%) had a relevant positive patch test, and 15 (57.7%) were polysensitized. The main positive sensitizers were nickel (38.5%), blue... Our data underscore the importance of performing a PT in AD children whose eczema has atypical distribution. The expressive percentage of positive tests, especially of allergens in skincare products, ...

IgE to wheat, prick test, and Patch test among children with celiac disease.

Celiac disease is one of the most common autoimmune disorders. This study aimed to evaluate the relationship between celiac disease and wheat sensitization.... In the current study, children aged < 18 years with confirmed celiac disease were included. Data were analyzed using SPSS.... Gastrointestinal problems were the most common indication for evaluation in terms of celiac disease. Prick and patch tests were positive in 43.4% and 34% respectively.... Prick test and patch test for wheat sensitization were positive in about 30-45% of the children for celiac disease....

Allergic reactivity for different dilutions of eugenol in repeated open application test and patch testing.

Eugenol is a known contact sensitiser included in fragrance mix I.... To assess the allergic reactivity to eugenol in different concentrations using patch test as well as repeated open application test (ROAT).... Overall 67 subjects from 6 European dermatology clinics participated in the study. The ROAT was performed for 21 days twice a day, applying 3 dilutions of eugenol (2.7%-0.5%) and a control. Before and... Out of the 34 subjects with contact allergy to eugenol, 21 (61.8%) showed a positive patch test before ROAT was performed, the lowest positive concentration was 0.031%. The ROAT was positive in 19 (55... Eugenol can provoke a positive patch test reaction in a very low dose; besides, this hypersensitivity may persist even if a former positive patch test is not reproduceable....

Effects of aluminium chloride added to common patch test substances.

A modulating effect of aluminium regarding type IV reactions might exist but has not been further investigated.... The aim of this study was to investigate the effect on patch test reactions when adding aluminium chloride hexahydrate (Al-Cl) to common test preparations.... Al-Cl in different concentrations was added to nickel sulphate 15.0% aqua (Ni), methylisothiazolinone 0.2% aqua (MI) and fragrance mix I 10.0% aqua/ethanol (FM I). The Ni preparations were tested in 1... Adding Al-Cl 20.0%/30.0% to Ni identified twice as many patients with contact allergy to nickel compared to Ni without Al-Cl. Adding Al-Cl 20.0%/10.0% to MI, decreased the patch test reactivity compar... Al-Cl 20.0% or 30.0% seems to enhance the patch test reactivity to Ni 15.0% aqua....